Chloé Friang

Chloé Friang is a highly experienced Senior Research Associate currently at Molecular Partners AG in Zurich since December 2018, with prior roles at Numab AG and Roche, where expertise in antibody-based product development was demonstrated through cloning, cell transfection, and FACS screening. Previous positions at Novartis involved generating humanized transgenic mouse models and conducting in vitro and in vivo studies related to cancer research. Chloé began a scientific career with a master's thesis on estradiol effects on breast cancer models and has interned at INSERM and CNRS, focusing on cancer research and nanoparticle synthesis for diabetes treatment. Educational credentials include a Master’s Degree in Health-Biology from Nantes Université and a Bachelor’s Degree in Biological Science from Heriot-Watt University.